Samalin Investment Counsel’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Buy |
24,954
+4,029
| +19% | +$74.3K | 0.18% | 183 |
|
|
2025
Q1 | $366K | Buy |
20,925
+6,668
| +47% | +$116K | 0.15% | 204 |
|
|
2024
Q4 | $247K | Buy |
14,257
+1,437
| +11% | +$24.9K | 0.11% | 244 |
|
|
2024
Q3 | $239K | Buy |
12,820
+202
| +2% | +$3.76K | 0.1% | 247 |
|
|
2024
Q2 | $194K | Sell |
12,618
-1,171
| -8% | -$18K | 0.09% | 261 |
|
|
2024
Q1 | $204K | Sell |
13,789
-239
| -2% | -$3.53K | 0.1% | 259 |
|
|
2023
Q4 | $200K | Sell |
14,028
-1,652
| -11% | -$23.6K | 0.1% | 255 |
|
|
2023
Q3 | $219K | Buy |
15,680
+322
| +2% | +$4.49K | 0.13% | 229 |
|
|
2023
Q2 | $181K | Sell |
15,358
-2,457
| -14% | -$28.9K | 0.1% | 252 |
|
|
2023
Q1 | $205K | Buy |
17,815
+150
| +0.8% | +$1.73K | 0.12% | 221 |
|
|
2022
Q4 | $220K | Buy |
17,665
+332
| +2% | +$4.13K | 0.14% | 210 |
|
|
2022
Q3 | $227K | Buy |
17,333
+268
| +2% | +$3.51K | 0.17% | 180 |
|
|
2022
Q2 | $238K | Sell |
17,065
-730
| -4% | -$10.2K | 0.17% | 184 |
|
|
2022
Q1 | $265K | Buy |
17,795
+3,970
| +29% | +$59.1K | 0.16% | 189 |
|
|
2021
Q4 | $187K | Sell |
13,825
-4,801
| -26% | -$64.9K | 0.11% | 229 |
|
|
2021
Q3 | $274K | Buy |
18,626
+2,343
| +14% | +$34.5K | 0.18% | 179 |
|
|
2021
Q2 | $296K | Sell |
16,283
-2,519
| -13% | -$45.8K | 0.19% | 175 |
|
|
2021
Q1 | $326K | Sell |
18,802
-116
| -0.6% | -$2.01K | 0.22% | 157 |
|
|
2020
Q4 | $329K | Sell |
18,918
-16,852
| -47% | -$293K | 0.25% | 145 |
|
|
2020
Q3 | $493K | Buy |
35,770
+17,398
| +95% | +$240K | 0.44% | 69 |
|
|
2020
Q2 | $265K | Sell |
18,372
-694
| -4% | -$10K | 0.28% | 120 |
|
|
2020
Q1 | $208K | Buy |
19,066
+282
| +2% | +$3.08K | 0.28% | 110 |
|
|
2019
Q4 | $400K | Buy |
+18,784
| New | +$400K | 0.34% | 79 |
|